In the early development stages of inhalation products, laser diffraction can be utilized for droplet size testing to quickly screen for products with valuable performance. However, a drawback of this method is its inability to differentiate between multiple active pharmaceutical ingredients (APIs) in a product. Therefore, in the later stages of product development, a cascade impactor must be employed to further evaluate the aerodynamic particle size distribution (APSD).